Loading...
Market
What will be the key political response to the Pediatric Cancer Research Bill after enactment?
2
Resolution / Starting Odds
Joe Biden praises the bill • 25%
Chuck Schumer praises the bill • 25%
Republicans criticize the bill • 25%
Other significant response • 25%
Public statements, press releases, or social media posts by political figures
Story
Senate Passes $190M Pediatric Cancer Research Bill, Initially Passed 384-4 by House on March 5, 2024
Dec 20, 2024, 07:42 PM
The pediatric cancer research funding bill, known as H.R. 3391 - Gabriella Miller Kids First Research Act 2.0, was passed by the Republican-controlled House on March 5, 2024, with an overwhelming vote of 384-4. However, the bill has been stalled in the Democrat-controlled Senate, led by Majority Leader Chuck Schumer, since it was received on March 6, 2024. Critics have pointed out that Democrats have blamed Republicans, including Elon Musk, for the lack of funding, despite the fact that the bill was already approved in the House. Recently, the Senate voted to pass the bill after months of delays, and it is now set to be sent to President Biden for final approval. The passage of the bill comes amid ongoing political debates regarding funding priorities, with some Democrats accusing Republicans of prioritizing tax cuts over essential funding for children's cancer research.
View original story
Similar markets
Neutral • 25%
No Statement • 25%
Opposed • 25%
Supportive • 25%
Amended • 25%
No Action • 25%
Rejected • 25%
Passed • 25%
Supportive • 25%
No official stance • 25%
Neutral • 25%
Opposed • 25%
Decrease Funding • 25%
No Amendments • 25%
Change Allocation • 25%
Increase Funding • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Undecided/No opinion • 25%
Not effective • 25%
Very effective • 25%
Somewhat effective • 25%
Other • 25%
No legislative action • 25%
Investigations into pharmaceutical companies • 25%
New regulations on vaccine transparency • 25%
No • 50%
Yes • 50%
Mixed reactions • 25%
Opposed • 25%
Supportive • 25%
No significant comment • 25%